Eli Lilly LLY Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $7.4B+168% | $6.64B+50.5% | $5.58B+475% | $5.66B+90.8% | $2.76B+23.0% | ||
| $509M+9.9% | $585.7M+20.7% | $470M+0.7% | $478.3M+15.4% | $463M+15.6% | ||
| $161M+4.5% | $136.1M-4.4% | $151.1M+13.4% | $184.8M-12.5% | $154M-3.4% | ||
| $5.33B+220% | $3.22B+30.3% | $8.84B+138% | $3.09B+111% | $1.67B+42.9% | ||
| $2.33B+54.0% | $2.55B+70.2% | $2.09B+54.6% | $1.7B+38.5% | $1.51B+53.1% | ||
| $1.06B— | $111.6M+37,100% | $549.4M— | $0— | $0— | ||
| -$3.92B-16.8% | -$2.8B-45.9% | -$2.98B+25.5% | -$1.83B+16.6% | -$3.35B-185% | ||
| $1.55B+15.0% | $1.35B+15.2% | $1.35B+14.9% | $1.35B+14.9% | $1.35B+15.1% | ||
| $2.36B+96.3% | $1.51B-26.6% | $708.1M+58.7% | $692.2M— | $1.2B— | ||
| $0-100% | —— | $6.71B+35.1% | —— | $6.46B+0.1% | ||
| $750M— | —— | —— | $778.1M+369% | $0-100% | ||
| -$3.47B-351% | -$2.88B— | $531M+151% | -$1.25B-180% | $1.38B+543% | ||
| -$1.99B-1,035% | —— | $6.42B+4,313% | $282.5M-63.0% | -$175M+51.2% | ||
| $3.01B+1,828% | $677.9M-30.7% | $6.75B+186% | $1.39B+476% | $156M-13.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Eli Lilly generate?
- Eli Lilly (LLY) generated $20.5B in operating cash flow over the trailing twelve months.
- What is Eli Lilly's free cash flow?
- After $8.7B of capital expenditures, Eli Lilly's free cash flow was $11.8B over the trailing twelve months, up 216.4% year over year.
- Where does Eli Lilly's cash flow data come from?
- Every line is extracted from Eli Lilly's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
